首页> 美国卫生研究院文献>BMJ Open Quality >A quality improvement project to improve the Medicare and Medicaid Services (CMS) sepsis bundle compliance rate in a large healthcare system
【2h】

A quality improvement project to improve the Medicare and Medicaid Services (CMS) sepsis bundle compliance rate in a large healthcare system

机译:一个质量改进项目用于提高大型医疗保健系统中的医疗保险和医疗补助服务(CMS)脓毒症包依从率

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sepsis is a leading cause of mortality and morbidity in hospitalised patients. The Centers for Medicare and Medicaid Services (CMS) mandated that US hospitals report sepsis bundle compliance rate as a quality process measure in October 2015. The specific aim of our study was to improve the CMS sepsis bundle compliance rate from 30% to 40% across 20 acute care hospitals in our healthcare system within 1 year.The study included all adult inpatients with sepsis sampled according to CMS specifications from October 2015 to September 2016. The CMS sepsis bundle compliance rate was tracked monthly using statistical process control charting. A baseline rate of 28.5% with 99% control limits was established. We implemented multiple interventions including computerised decision support systems (CDSSs) to increase compliance with the most commonly missing bundle elements.Compliance reached 42% (99% statistical process control limits 18.4%–38.6%) as CDSS was implemented system-wide, but this improvement was not sustained after CMS changed specifications of the outcome measure. Difficulties encountered elucidate shortcomings of our study methodology and of the CMS sepsis bundle compliance rate as a quality process measure.
机译:败血症是住院患者死亡率和发病率的主要原因。美国医疗保险和医疗补助服务中心(CMS)规定,美国医院应在2015年10月将败血症包依从率报告为一项质量过程指标。我们研究的具体目的是将CMS败血症包依从率从30%提高到40%在1年内,我们的医疗系统中有20家急诊医院。该研究纳入了2015年10月至2016年9月根据CMS规范对所有脓毒症成年住院患者进行的抽样调查。使用统计过程控制图每月追踪CMS脓毒症的依从率。建立基线率为28.5%,控制范围为99%。我们实施了包括计算机决策支持系统(CDSSs)在内的多种干预措施,以提高对最常丢失的捆绑软件要素的合规性。在整个系统范围内实施CDSS时,合规性达到42%(统计过程控制限制为99%的18.4%–38.6%)。 CMS更改结果指标后,改善没有持续。遇到的困难阐明了我们的研究方法和CMS败血症捆绑包依从率(作为质量过程衡量指标)的缺点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号